A special focus is placed on collaboration with national partner organisations. These strategic partnerships create new synergies in continuing education, research, and clinical care. At the same time, close cooperation strengthens the joint representation of neurological interests in healthcare policy and tariff-related matters and provides the basis for shared statements and recommendations.

Together with the Swiss Society for Clinical Neurophysiology (SGKN), curricula have been better aligned, foundations for future joint certifications established, and interdisciplinary CME programs further developed. The goal is to meet the complex demands of modern neurological care and strengthen the quality of neurological education and training in Switzerland over the long term.

A visible sign of this intensified collaboration is the 1st Swiss NeuroWeek 2026, which is organized jointly with several partner societies.

Swiss NeuroWeek represents a new national format bringing together different areas of clinical neuroscience under one roof for the first time. Its goal is to discuss current developments in research, clinical practice, and innovation through an interdisciplinary approach and to jointly advance neurology in Switzerland.

The SNS understands interdisciplinarity not merely as collaboration between disciplines, but as a key prerequisite for modern, connected, and future-oriented neurology.

The Swiss Neurological Society (SNS) has published a Swiss statement on family planning for people with multiple sclerosis.

Rare neurological diseases (RNDs) each affect only a small number of people, but together they impact around 7% of the population — more than half a million people in Switzerland alone. Diagnosis, treatment, and care are often complex, interdisciplinary, and organizationally demanding. Many patients remain without a clear diagnosis or coordinated care for long periods of time.

For this reason, the SNS and its task force for rare neurological diseases, are actively committed to improving visibility, networking, and care for rare neurological diseases in Switzerland.

The SNS supports the initiative of the Swiss Network for Rare Neurological Disorders of the Central Nervous System (Swiss RND CNS), which seeks recognition by the National Coordination of Rare Diseases (KOSEK). The goal is to establish a nationwide network providing neurological primary care through private practice neurologists combined with regular follow-up at specialized Centres of Expertise.

Together with the Swiss RND CNS at the University of Bern, the SNS Task Force “Rare Diseases” works to pool expertise, further develop care structures, and strengthen collaboration between specialized centers, hospitals, private practices, and other healthcare professionals.

An important milestone for the structured care of rare neurological diseases was achieved in 2021 with the KOSEK recognition of the Swiss Neuromuscular Network.

“Our primary goal is to improve the care of patients with rare neurological diseases and to strengthen coordination and collaboration throughout Switzerland through an integrated care network. Only by acting together can we improve both the visibility and funding of this still underfunded field.” — PD Dr. med. Tatiana Brémovà-Erlt, PhD, member of the SNS Task Force Rare Diseases | Interview, SNS Annual Report 2025, pp. 60–61

The SNS is committed to strengthening care, research, and public awareness of rare neurological diseases over the long term and improving access to specialized neurological expertise.

SNS media release of 29 October 2025: World Stroke Day - Every minute counts​​​​​​​